Národny ustav srdcovych a cievnych chorob a.s. — Clinical Trial Site

18 Registered trials

5 Currently recruiting

Organisation

Národny ustav srdcovych a cievnych chorob a.s.

Location

Bratislava, Slovakia

Identifier

ORG-100040853

Address

Pod Krasnou Horkou 1, Nove Mesto, 831 01, Slovakia

Departments

#3346: Oddelenie akútnej kardiológie - koronárnej starostlivosti
#4144: Ambulantné oddelenie
#4145: Oddelenie akútnej kardiológie - koronárnej starostlivosti
#4158: Oddelenie intervenčnej kardiológie
3007; Oddelenie akútnej kardiológie - koronárnej starostlivosti
3008; Ambulantné oddelenie
3032; Oddelenie kardiológie a angiológie
4144: Ambulantné oddelenie
Ambulantne oddelenie
Cardiology Clinic - Arrhythmology Department
Department of Acute Cardiology
Department of Cardiology
Klinika kardiologie a angiologie LF SZU
NA
Oddelenia zlyhavania a transplantacie srdca
Oddelenie anesteziológie a intenzívnej medicíny
Oddelenie arytmii a kardiostimulacie
Oddelenie zlyhávania a transplantácie
Oddelenie zlyhávania a transplantácie srdca
Pediatric Cardiac Center, Department of Cardiology

Clinical trials at this site (18)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
A Study to Learn About the Study Medicine Called Aztreonam-Avibactam in Neonates and Infants Less Than 9 Months of Age With Suspected or Con… Pending

2023-507757-15-01 Sepsis 4
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study … Recruiting

2023-505962-28-00 Persistent symptomatic atrial fibrillation 5 2024-05-08
A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig… Recruiting

2025-520519-14-00 Atherosclerotic Cardiovascular Disease 5 2025-09-03
A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficien… Recruiting

2024-519059-28-00 Chronic Heart Failure 5 2025-07-17
Open-label, single-arm, non-controlled trial to evaluate the safety and tolerability of treprostinil sodium in children below the age of 18 … Recruiting

2023-505082-91-00 Pulmonary Arterial Hypertension (PAH) 5 2024-05-29
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation. Ended

2022-501939-16-00 Heart failure (HF) with mildly reduced ejection fractio 5 2023-05-09
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24
A Phase 3 study to compare long-term efficacy and safety of macitentan 75 mg versus 10 mg in Pulmonary Arterial Hypertension. Ended

2024-515669-32-00 Pulmonary arterial hypertension 5 2020-06-30
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06
A study to test whether BI 765845 helps people who have had a heart attack Ended

2022-502788-39-00 acute myocardial infarction 4 2023-11-27
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24